https://www.selleckchem.com/pr....oducts/Romidepsin-FK
Introduction Administering intravenous thrombolytic therapy within 60 minutes on arrival in any healthcare facility is challenging, especially when done by Emergency Medicine Physicians (EMP) via telemedicine in centres without onsite neurology cover. Prior quality improvement interventions have improved median Door-to-Needle (DTN) timings in our centre; however, it still falls short of the DTN target of 60 minutes. Methods Various quality improvement interventions were implemented over four months by a multi-disciplinary teles